Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuejun Wen

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Acta Biomaterialia|November 17, 2021
Corrigendum to 'Sodium alginate/collagen/stromal cell-derived factor-1 neural scaffold loaded with BMSCs promotes neurological function recovery after traumatic brain injury' [Acta Biomaterialia 131 (2021) 185-197]Shanshan Ma, Jiankang Zhou, Tuanjie Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Clinical Evaluation of <sup>68</sup>Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α<sub>v</sub>β<sub>3</sub> in Various Cancer TypesLiang Zhao, Xuejun Wen, Weizhi Xu, et al.
Molecular Pharmaceutics|June 2, 2022
PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor EffectXuejun Wen, Xueyuan Zeng, Xingxing Cheng, et al.
Clinical Nuclear Medicine|September 8, 2023
A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various CancersJie Zang, Rong Lin, Xuejun Wen, et al.
Theranostics|November 8, 2019
Integrin α<sub>v</sub>β<sub>3</sub>-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacyHaojun Chen, Liang Zhao, Kaili Fu, et al.
Stem Cell Research|November 21, 2017
Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutationZhilei Wang, Pei Zhang, Yanlin Wang, et al.
Acta Biomaterialia|July 4, 2021
Sodium alginate/collagen/stromal cell-derived factor-1 neural scaffold loaded with BMSCs promotes neurological function recovery after traumatic brain injuryShanshan Ma, Jiankang Zhou, Tuanjie Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2024
Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeuticsHongzhang Yang, Xinying Zeng, Jia Liu, et al.
Biomaterials|July 9, 2018
pH-sensitive radiolabeled and superfluorinated ultra-small palladium nanosheet as a high-performance multimodal platform for tumor theranosticsZhide Guo, Mei Chen, Chenyu Peng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2026
Enhanced therapeutic efficacy of sequential ¹⁷⁷Lu/²²⁵Ac-LNC1004 FAP-targeted radionuclide therapy combined with anti-PD-L1 blockade in pancreatic cancerMengqi Shi, Jia Liu, Heng Li, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Acta Biomaterialia|November 17, 2021
Corrigendum to 'Sodium alginate/collagen/stromal cell-derived factor-1 neural scaffold loaded with BMSCs promotes neurological function recovery after traumatic brain injury' [Acta Biomaterialia 131 (2021) 185-197]Shanshan Ma, Jiankang Zhou, Tuanjie Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Clinical Evaluation of <sup>68</sup>Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α<sub>v</sub>β<sub>3</sub> in Various Cancer TypesLiang Zhao, Xuejun Wen, Weizhi Xu, et al.
Molecular Pharmaceutics|June 2, 2022
PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor EffectXuejun Wen, Xueyuan Zeng, Xingxing Cheng, et al.
Clinical Nuclear Medicine|September 8, 2023
A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various CancersJie Zang, Rong Lin, Xuejun Wen, et al.
Theranostics|November 8, 2019
Integrin α<sub>v</sub>β<sub>3</sub>-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacyHaojun Chen, Liang Zhao, Kaili Fu, et al.
Stem Cell Research|November 21, 2017
Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutationZhilei Wang, Pei Zhang, Yanlin Wang, et al.
Acta Biomaterialia|July 4, 2021
Sodium alginate/collagen/stromal cell-derived factor-1 neural scaffold loaded with BMSCs promotes neurological function recovery after traumatic brain injuryShanshan Ma, Jiankang Zhou, Tuanjie Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2024
Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeuticsHongzhang Yang, Xinying Zeng, Jia Liu, et al.
Biomaterials|July 9, 2018
pH-sensitive radiolabeled and superfluorinated ultra-small palladium nanosheet as a high-performance multimodal platform for tumor theranosticsZhide Guo, Mei Chen, Chenyu Peng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2026
Enhanced therapeutic efficacy of sequential ¹⁷⁷Lu/²²⁵Ac-LNC1004 FAP-targeted radionuclide therapy combined with anti-PD-L1 blockade in pancreatic cancerMengqi Shi, Jia Liu, Heng Li, et al.
Pageof 15